The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126113501 12611350 1 I 20151201 20160725 20160801 20160801 EXP US-BAUSCH-BL-2016-017920 BAUSCH AND LOMB 61.76 YR F Y 0.00000 20160801 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126113501 12611350 1 PS XIFAXAN RIFAXIMIN 1 Oral U 21361 550 MG TABLET BID
126113501 12611350 2 SS RIBAVIRIN. RIBAVIRIN 1 Unknown U 18859
126113501 12611350 3 I OLYSIO SIMEPREVIR 1 Unknown U 0
126113501 12611350 4 SS SOVALDI SOFOSBUVIR 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126113501 12611350 1 Hepatic encephalopathy
126113501 12611350 2 Hepatitis C
126113501 12611350 3 Hepatitis C
126113501 12611350 4 Hepatitis C

Outcome of event

Event ID CASEID OUTC COD
126113501 12611350 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126113501 12611350 Arrhythmia
126113501 12611350 Bone abscess
126113501 12611350 Cardiac disorder
126113501 12611350 Chest pain
126113501 12611350 Drug interaction
126113501 12611350 Guillain-Barre syndrome
126113501 12611350 Herpes zoster
126113501 12611350 Immunosuppression
126113501 12611350 Infection
126113501 12611350 Injury
126113501 12611350 Loss of consciousness
126113501 12611350 Malaise
126113501 12611350 Memory impairment
126113501 12611350 Pyrexia
126113501 12611350 Skin infection
126113501 12611350 Stress

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126113501 12611350 1 2014 201512 0
126113501 12611350 2 201405 20141007 0
126113501 12611350 3 201405 20141007 0
126113501 12611350 4 201405 20141007 0